Friday, July 10, 2026

Drug profile · INN

atosiban

atosiban (ATOSIBAN SUN) is a oxytocin receptor antagonist.

EMA: approved Genito-urinary system and sex hormones (G02) G02CX01
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — atosiban
Class
Genito-urinary system and sex hormones (G02)
Route
Patents
0
Programs
3
Data quality
0.83

Quick answer

atosiban (ATOSIBAN SUN) is a oxytocin receptor antagonist.

Key facts

INN atosiban
Brand ATOSIBAN SUN
Mechanism Oxytocin receptor antagonist
Target Oxytocin receptor
Therapeutic class Genito-urinary system and sex hormones (G02)
ATC code G02CX01

Mechanism of action

Oxytocin receptor antagonist

Primary target: Oxytocin receptor

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. Atosiban Approved · University of Hong · Subfertility
  2. Atosiban Unknown · NORTHWEST BIOTHERAPEUTICS · Infertility
  3. atosiban Unknown · Hospital Authority · Repeated Implantation Failure

Related & competitor drugs

  1. apomorphine Genito-urinary system and sex hormones (G04)
  2. mirabegron Genito-urinary system and sex hormones (G04)
  3. oxybutynin Genito-urinary system and sex hormones (G04)
  4. raloxifene Genito-urinary system and sex hormones (G03)
  5. sildenafil Genito-urinary system and sex hormones (G04)
  6. silodosin Genito-urinary system and sex hormones (G04)

Frequently asked questions

What is atosiban?

atosiban (ATOSIBAN SUN) is a oxytocin receptor antagonist.

What is the brand name for atosiban?

ATOSIBAN SUN is a marketed brand name for atosiban. Check FDA Drugs@FDA for the current US label holder and prescribing information.